This is a tech startup’s dream come true-a one stop marketplace for algorithm developers
Algorithmia utilizes the same marketplace model that startups have applied to such a variety of different products and ventures, including everything from graphic design to real estate and ecommerce. While OpenAI shares raw AI research, Algorithmia offers working algorithms designed to slot directly into new services
In recent time, Google and Facebook have snapped up such a large number of researchers at the heart of the deep learning movement, an AI movement that is quickly reinventing everything from speech recognition to security. Along these lines, Musk and Altman snatched a few top AI researchers from Google and Facebook and promised to share their work with the world on stage .
“Algorithmia was born in 2013 with the goal of advancing the art of algorithm development, discovery and use. As developers ourselves we believe that given the right tools the possibilities for innovation and discovery are limitless. Today we build what we believe to be the next era of programming: a collaborative, always live and community driven approach to making the machines that we interact with better,” quotes the website.
Anybody can upload an algorithm to the market, and after that people/companies can pay to utilize it. The author of the algorithm chooses the price of every API and after that 70 percent of the proceeds go to the author, with Algorithmia keeping the rest. At the point when an algorithm is totally open source, Algorithmia charges just for the computing power used.
AdvertisementThe company last raised $2.4 million in 2014 led by Madrona Venture Group. While it may not strike Zuckerberg's standards, it is still noteworthy that 24 hours of coding and a modest bunch of algorithms can construct an app for a startup.
- Chennai volunteer for SII's Covid vaccine claims Rs 5 cr compensation for health complications
- ASEAN distances from China's Covid vaccine diplomacy
- Centre seeks 300-400 mn vaccine doses, says SII's Poonawalla
- Adar Poonawalla says SII will seek emergency use authorisation for AstraZeneca COVID-19 vaccine in two weeks
- PM reviews vaccine progress at Serum Institute in Pune